Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

825.91 +3.40 (+0.41%)
Official Closing Price Updated: 7:00 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,737,270
Open 808.98
Bid (Size) 822.00 (1)
Ask (Size) 825.88 (1)
Prev. Close 822.51
Today's Range 789.40 - 828.01
52wk Range 711.40 - 972.53
Shares Outstanding N/A
Dividend Yield 0.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eli Lilly's Cholesterol Drug Reduces Genetic Heart Disease Risk Factor By 93.9%
Eli Lilly's lepodisiran met Phase 2 trial goals, significantly lowering Lp(a) levels. A Phase 3 study is enrolling to assess its impact on cardiovascular events. 
Via Benzinga
Palatin Technologies' Obesity Drug Co-Administered With Eli Lilly's Blockbuster Drug Shows 4.4% Reduction In Weight
Palatin's study shows co-administering bremelanotide with tirzepatide led to greater weight loss than tirzepatide alone, with further analysis ongoing. 
Via Benzinga

Performance

YTD
+6.1%
+6.1%
1 Month
-10.3%
-10.3%
3 Month
+6.7%
+6.7%
6 Month
-6.8%
-6.8%
1 Year
+8.6%
+8.6%

More News

Read More
1 Growth Stock With Major Catalysts on the Way to Buy and Hold
Via The Motley Fool
Is Hims & Hers Stock Too Cheap to Pass Up?
Via The Motley Fool
Benzinga Bulls And Bears: Chevron, Microsoft, Nike — And Tariffs Have Automotive Sector Reeling
Via Benzinga
Microsoft Co-Founder Bill Gates Praises China As A Pioneer In Solar, Batteries, And AI: Warns Tensions Are Stifling Global Innovation
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Eli Lilly Stock Up 1% After Key Signal, Despite S&P 500's ~2% Drop
Via Benzinga
Topics Stocks
Exposures US Equities
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen
Via Benzinga
Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1
Via Investor's Business Daily
Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too?
Via The Motley Fool
Topics ETFs Economy Government
Exposures Economy Political Tariff
Billionaires Stanley Druckenmiller, Chase Coleman, and Stephen Mandel Jr. Are Piling Into This Growth Stock That's Beating the S&P 500
Via The Motley Fool
Topics Stocks
Exposures US Equities
Here's How Much $1000 Invested In Eli Lilly 20 Years Ago Would Be Worth Today
Via Benzinga
Why Novo Nordisk Stock Dipped on Thursday
Via The Motley Fool
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Via Investor's Business Daily
Topics Government
Exposures Political
1 Growth Stock Down 40% to Buy and Hold Forever
Via The Motley Fool
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025
Via The Motley Fool
Organovo Provides Business Update
From Organovo, Inc.
Via GlobeNewswire
Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements
Via FinancialNewsMedia
Price Targets Show These 3 Stocks Near the $1 Trillion Mark
Via MarketBeat
Novo Nordisk Stock Sinks To 52-Week Lows: Weight Loss Boom Losing Steam?
Via Benzinga
Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study
Via Investor's Business Daily
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here
Via Benzinga
Topics ETFs
Direxion Expands Single Stock Leveraged & Inverse ETF Lineup for Exposure to Eli Lilly & Palo Alto Networks
Via News Direct
Topics ETFs
2 No-Brainer Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
From Organovo, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 825.91
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 03/31/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.